Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA’s Office Of Regulatory Policy To Be Headed By Covington & Burling Alum

This article was originally published in The Pink Sheet Daily

Executive Summary

Grail Sipes, who joined FDA three years ago as a senior regulatory counsel, has been named permanent director of ORP; Department of Justice’s Deputy Inspector General appointed to head Office of Compliance.

You may also be interested in...



Top US FDA Drug Policy Leader Leaving For White House Detail

Grail Sipes, CDER deputy center director for regulatory policy, will move to the Executive Office of the President next month.

FDA Again Taps Compliance Director For Globalization Post

Howard Sklamberg, currently director of the CDER Office of Compliance, will take over the Office of Global Regulatory Operations and Policy after a year as CDER compliance office director.

Social Media Data Gains Prominence In Patient-Focused Drug Development

FDA guidances have provided ‘major step forward’ for use of social media data, Roche researcher notes. Agency staffer offers checklist for collecting patient experience data in this realm.

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS077663

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel